309A — Cosmos Chouzai Pharmacy Co Income Statement
0.000.00%
Consumer DefensivesHighly SpeculativeMicro Cap
Annual income statement for Cosmos Chouzai Pharmacy Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Tanshin |
| Standards: | JAS | JAS | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 5,804 | 6,187 | 6,293 |
| Cost of Revenue | |||
| Gross Profit | 2,558 | 2,744 | 2,822 |
| Selling / General / Administrative Expenses | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 5,774 | 5,991 | 6,071 |
| Operating Profit | 30 | 196 | 222 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 140 | 204 | 245 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 111 | 95 | 139 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | 21 | 28 | 139 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 18 | 26 | 138 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 35.9 | 38.9 | 60.3 |
| Dividends per Share | |||
| Special Dividends per Share |